Metastatic, Her-2 Amplified Lacrimal Gland Carcinoma with Response to Lapatinib Treatment

Carcinoma of the lacrimal gland is a rare malignancy, limiting opportunities to develop new therapeutic regimens through clinical trials. There are no standard guidelines on optimal treatment of lacrimal gland carcinoma. In addition, lacrimal gland carcinoma includes several different subtypes with...

Descripción completa

Detalles Bibliográficos
Autor principal: Dennie, Trevor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332983/
https://www.ncbi.nlm.nih.gov/pubmed/25722902
http://dx.doi.org/10.1155/2015/262357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332983/
https://www.ncbi.nlm.nih.gov/pubmed/25722902
http://dx.doi.org/10.1155/2015/262357

Ejemplares similares